A Novel Method Of Vaccination With An Attenuated RSV Vaccine Formulation Read more about A Novel Method Of Vaccination With An Attenuated RSV Vaccine Formulation US Application 62/263,405Filed on 2015-12-04
A Novel Method Of Vaccination With An Attenuated RSV Vaccine Formulation Read more about A Novel Method Of Vaccination With An Attenuated RSV Vaccine Formulation US Application 62/259,472Filed on 2015-11-24
A Novel Method Of Vaccination With An Attenuated RSV Vaccine Formulation Read more about A Novel Method Of Vaccination With An Attenuated RSV Vaccine Formulation US Application 62/251,030Filed on 2015-11-04
RECOMBINANT RESPIRATORY SYNCTIAL VIRUS (RSV) STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS Read more about RECOMBINANT RESPIRATORY SYNCTIAL VIRUS (RSV) STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS US Application 62/266,206Filed on 2015-12-11
Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use Read more about Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use US Application 62/219,851Filed on 2015-09-17
Neutralizing Antibodies to GP120 and Their Use Read more about Neutralizing Antibodies to GP120 and Their Use US Application 62/250,378Filed on 2015-11-03
Methods for Inhibiting Human Immunodeficiency Virus (HIV) Release From Infected Cells Read more about Methods for Inhibiting Human Immunodeficiency Virus (HIV) Release From Infected Cells US Application 62/271,726Filed on 2015-12-28
SELF-ASSEMBLING INSECT FERRITIN NANOPARTICLES FOR DISPLAY OF CO-ASSEMBLED TRIMERIC ANTIGENS Read more about SELF-ASSEMBLING INSECT FERRITIN NANOPARTICLES FOR DISPLAY OF CO-ASSEMBLED TRIMERIC ANTIGENS US Application 62/355,212Filed on 2016-06-27
Compounds for Modulating FceRIB Expression and Uses Thereof Read more about Compounds for Modulating FceRIB Expression and Uses Thereof US Application 62/289,447Filed on 2016-02-01
MODIFIED ANTHRAX TOXIN PROTECTIVE ANTIGEN Read more about MODIFIED ANTHRAX TOXIN PROTECTIVE ANTIGEN US Application 62/210,771Filed on 2015-08-27